Published in Neuromuscul Disord on July 13, 2012
Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial. PLoS One (2015) 0.94
Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy. Muscle Nerve (2015) 0.86
Upper arm and cardiac magnetic resonance imaging in Duchenne muscular dystrophy. Ann Clin Transl Neurol (2016) 0.75
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy. Neuromuscul Disord (2016) 0.75
An objective and standardized test of hand function. Arch Phys Med Rehabil (1969) 4.67
Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil (1995) 2.45
Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve (1981) 2.06
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clin Investig (Lond) (2011) 1.84
A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord (2005) 1.44
A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy. Dev Med Child Neurol (2012) 1.20
Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy. J Child Neurol (2010) 1.10
Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord (2011) 0.94
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol (2009) 8.42
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol (2009) 4.27
A randomized study of alglucosidase alfa in late-onset Pompe's disease. N Engl J Med (2010) 3.05
MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain (2006) 2.77
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler (2008) 2.28
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord (2010) 2.14
ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children. Pediatr Crit Care Med (2016) 2.02
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol (2010) 1.80
Sleep-related eating disorder induced by olanzapine. J Clin Psychiatry (2002) 1.73
Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol (2009) 1.67
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol (2013) 1.63
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve (2013) 1.63
Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol (2006) 1.59
Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet (2004) 1.51
Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet (2002) 1.46
Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve (2014) 1.41
Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) (2014) 1.39
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. PLoS One (2013) 1.34
Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int (2011) 1.31
Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol (2013) 1.30
Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J Am Soc Echocardiogr (2008) 1.24
Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol (2010) 1.22
Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol (2004) 1.20
A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy. Dev Med Child Neurol (2012) 1.20
High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy. Neuromuscul Disord (2002) 1.19
Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann Neurol (2010) 1.18
Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study. PLoS One (2013) 1.14
Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene. Hum Mutat (2011) 1.13
Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J Neurosci (2011) 1.08
Effect of bracing on paralytic scoliosis secondary to spinal cord injury. J Spinal Cord Med (2004) 1.08
Another cause of hyperglyceroluria: aquaporin 7 gene mutation. J Pediatr Gastroenterol Nutr (2013) 1.05
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol (2005) 1.04
Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS One (2013) 1.03
Translational and regulatory challenges for exon skipping therapies. Hum Gene Ther (2014) 1.02
Inactivation of calcium-binding protein genes induces 160 Hz oscillations in the cerebellar cortex of alert mice. J Neurosci (2004) 1.01
Thalamic atrophy in infants with PVL and cerebral visual impairment. Early Hum Dev (2006) 1.00
Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial. Neuromuscul Disord (2011) 1.00
Early neurodevelopmental assessment in Duchenne muscular dystrophy. Neuromuscul Disord (2013) 0.97
Early onset myoclonic epilepsy and 15q26 microdeletion: observation of the first case. Epilepsia (2009) 0.96
ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders. Neuromuscul Disord (2007) 0.95
Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord (2011) 0.94
Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts. Mol Ther (2012) 0.93
Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's type. Clin Pharmacokinet (2002) 0.92
Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach. Neurogenetics (2014) 0.92
Use of complementary and alternative medicine in epilepsy. Curr Neurol Neurosci Rep (2006) 0.92
Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational. PLoS Curr (2013) 0.92
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome. Eur J Hum Genet (2010) 0.91
Leisure characteristics of the pediatric spinal cord injury population. J Spinal Cord Med (2004) 0.91
The natural history of cardiac and pulmonary function decline in patients with duchenne muscular dystrophy. Spine (Phila Pa 1976) (2011) 0.91
Targeted calretinin expression in granule cells of calretinin-null mice restores normal cerebellar functions. FASEB J (2005) 0.90
CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy. Eur J Paediatr Neurol (2007) 0.90
Variable phenotypes associated with mutations in DOK7. Muscle Nerve (2008) 0.89
Rasch analysis of clinical outcome measures in spinal muscular atrophy. Muscle Nerve (2013) 0.89
Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr (2012) 0.89
Visual development in infants with prenatal post-haemorrhagic ventricular dilatation. Arch Dis Child Fetal Neonatal Ed (2006) 0.89
Muscle MRI in Becker muscular dystrophy. Neuromuscul Disord (2012) 0.86
BK channels control cerebellar Purkinje and Golgi cell rhythmicity in vivo. PLoS One (2009) 0.86
Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1. Hum Genet (2004) 0.86
Choosing the right clinical outcome measure: from the patient to the statistician and back. Neuromuscul Disord (2010) 0.85
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. Muscle Nerve (2011) 0.85
Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutation. Amyotroph Lateral Scler (2010) 0.84
Peripheral neuropathy in an outpatient cohort of patients with Sjögren's syndrome. Muscle Nerve (2006) 0.84
Immediate relief of Mycoplasma pneumoniae encephalitis symptoms after intravenous immunoglobulin. Pediatr Neurol (2009) 0.84
Helicopter emergency medical service in Italy: reality and perspectives. Air Med J (2007) 0.84
195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands. Neuromuscul Disord (2013) 0.82
A prospective evaluation of the WeeFIM in patients with cerebral palsy undergoing orthopaedic surgery. J Pediatr Orthop (2006) 0.82
From electrophysiology to chromatin: a bottom-up approach to Angelman syndrome. Ann N Y Acad Sci (2004) 0.81
Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery. Hum Mol Genet (2007) 0.81
A mitochondrial tRNA aspartate mutation causing isolated mitochondrial myopathy. Am J Med Genet A (2005) 0.81
Timed motor test for wheelchair users: initial development and application in children with spinal cord injury. J Spinal Cord Med (2004) 0.81
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. Ann Neurol (2015) 0.80
111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9-11 November 2002, Naarden, The Netherlands. Neuromuscul Disord (2004) 0.80
Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire. Neuromuscul Disord (2009) 0.80
Age dependence of strain determinant on mice motor coordination. Brain Res (2005) 0.79
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report. Neuromuscul Disord (2012) 0.79
Qualitative and quantitative skeletal muscle ultrasound in late-onset acid maltase deficiency. Muscle Nerve (2011) 0.79
Fast oscillation in the cerebellar cortex of calcium binding protein-deficient mice: a new sensorimotor arrest rhythm. Prog Brain Res (2005) 0.78
Effects of maternal alcohol consumption during breastfeeding on motor and cerebellar Purkinje cells behavior in mice. Neurosci Lett (2009) 0.78
Developing normalized strength scores for neuromuscular research. Muscle Nerve (2012) 0.78
Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy. Pediatr Pulmonol (2012) 0.78
Homozygosity for aquaporin 7 G264V in three unrelated children with hyperglyceroluria and a mild platelet secretion defect. Genet Med (2012) 0.78
The effect of Luque-Galveston fusion on curve, respiratory function and quality of life in Duchenne muscular dystrophy. Acta Orthop Belg (2011) 0.77
Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome. Orphanet J Rare Dis (2013) 0.76
Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatr Diabetes (2009) 0.76